id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2023-E-3236-0001,FDA,FDA-2023-E-3236,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2023-08-18T04:00:00Z,2023,8,2023-08-18T04:00:00Z,,2023-08-18T13:17:30Z,,0,0,0900006485da4b40
FDA-2023-E-3236-0002,FDA,FDA-2023-E-3236,"Patent Extension Application from Finnegan, Henderson, Farabow, Garrett & Dunner, LLP (on behalf of BioArtic AB)",Other,Application,2023-08-18T04:00:00Z,2023,8,2023-08-18T04:00:00Z,,2023-08-18T13:17:40Z,,0,0,0900006485da4b42